New treatment against Duchenne muscular dystrophy

View source ↗

Summary

The European Medicines Agency announced the approval of Duvyzat as a new treatment for Duchenne muscular dystrophy, for patients aged six and older.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Duvyzat

Snippet

Duvyzat can be used in a wide patient population from the age of six